Published in BJU Int on December 11, 2009
A pilot study combining a GC-sensor device with a statistical model for the identification of bladder cancer from urine headspace. PLoS One (2013) 1.51
Collectives of diagnostic biomarkers identify high-risk subpopulations of hematuria patients: exploiting heterogeneity in large-scale biomarker data. BMC Med (2013) 0.80
Is it time to re-design the haematuria clinic? BJU Int (2010) 0.75
Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting. Eur Urol (2010) 4.45
Cardiovascular outcomes in patients with locally advanced and metastatic prostate cancer treated with luteinising-hormone-releasing-hormone agonists or transdermal oestrogen: the randomised, phase 2 MRC PATCH trial (PR09). Lancet Oncol (2013) 3.85
A review of current guidelines and best practice recommendations for the management of nonmuscle invasive bladder cancer by the International Bladder Cancer Group. J Urol (2011) 1.84
Investigating Black-White differences in prostate cancer prognosis: A systematic review and meta-analysis. Int J Cancer (2008) 1.73
The risk of prostate cancer amongst black men in the United Kingdom: the PROCESS cohort study. Eur Urol (2007) 1.62
The risk of prostate cancer amongst South Asian men in southern England: the PROCESS cohort study. BJU Int (2008) 1.53
A pilot study combining a GC-sensor device with a statistical model for the identification of bladder cancer from urine headspace. PLoS One (2013) 1.51
HDR Brachytherapy in the Management of High-Risk Prostate Cancer. Adv Urol (2012) 1.45
Scoring systems used for the interpretation and reporting of multiparametric MRI for prostate cancer detection, localization, and characterization: could standardization lead to improved utilization of imaging within the diagnostic pathway? J Magn Reson Imaging (2012) 1.18
Sildenafil inhibits the formation of superoxide and the expression of gp47 NAD[P]H oxidase induced by the thromboxane A2 mimetic, U46619, in corpus cavernosal smooth muscle cells. BJU Int (2005) 1.10
Antibiotics for transrectal ultrasonography-guided prostate biopsy: are we practising evidence-based medicine? BJU Int (2008) 1.06
Men's and carers' experiences of care for prostate cancer: a narrative literature review. Health Expect (2009) 1.04
A three-centre experience of orthotopic neobladder reconstruction after radical cystectomy: revisiting the initial experience, and results in 104 patients. BJU Int (2008) 1.02
Effect of hydrogen sulphide-donating sildenafil (ACS6) on erectile function and oxidative stress in rabbit isolated corpus cavernosum and in hypertensive rats. BJU Int (2009) 0.98
Effect of sildenafil citrate and a nitric oxide donating sildenafil derivative, NCX 911, on cavernosal relaxation and superoxide formation in hypercholesterolaemic rabbits. Eur J Pharmacol (2005) 0.95
The Prostate Care Questionnaire for Carers (PCQ-C): reliability, validity and acceptability. BMC Health Serv Res (2009) 0.94
Screen-detected prostate cancer and the insulin-like growth factor axis: results of a population-based case-control study. Int J Cancer (2004) 0.90
A self-report-based study of the incidence and associations of sexual dysfunction in survivors of intensive care treatment. Intensive Care Med (2006) 0.89
The prostate care questionnaire for patients (PCQ-P): reliability, validity and acceptability. BMC Health Serv Res (2009) 0.88
Fibronectin confers survival against chemotherapeutic agents but not against radiotherapy in DU145 prostate cancer cells: involvement of the insulin like growth factor-1 receptor. Prostate (2010) 0.88
Population-based analysis of prostate-specific antigen (PSA) screening in younger men (<55 years) in Australia. BJU Int (2013) 0.87
Dihydrotestosterone sensitises LNCaP cells to death induced by epigallocatechin-3-Gallate (EGCG) or an IGF-I receptor inhibitor. Prostate (2009) 0.87
Macroscopic haematuria and urological cancer. Br J Gen Pract (2003) 0.86
The administration of folic acid improves erectile function and reduces intracavernosal oxidative stress in the diabetic rabbit. BJU Int (2008) 0.85
Penicillamine administration reverses the inhibitory effect of hyperhomocysteinaemia on endothelium-dependent relaxation in the corpus cavernosum in the rabbit. BJU Int (2006) 0.85
The role of hexylaminolaevulinate in the diagnosis and follow-up of non-muscle-invasive bladder cancer. BJU Int (2010) 0.83
The trends in prostate specific antigen usage amongst United Kingdom urologists--a questionnaire based study. BMC Urol (2008) 0.83
A three-centre experience of orthotopic neobladder reconstruction after radical cystectomy: initial results. BJU Int (2004) 0.83
Penicillamine administration reverses the inhibitory effect of hyperhomocysteinaemia on endothelium-dependent relaxation and superoxide formation in the aorta of the rabbit. Eur J Pharmacol (2006) 0.83
Homocysteine and copper interact to promote type 5 phosphodiesterase expression in rabbit cavernosal smooth muscle cells. Asian J Androl (2008) 0.83
Significance of novel bioinorganic anodic aluminum oxide nanoscaffolds for promoting cellular response. Nanotechnol Sci Appl (2011) 0.81
Differences in the epidemiology and presentation of prostate cancer in Black and White men in England: lessons learnt from the process study. BJU Int (2008) 0.81
Incidence of prostate cancer in Sri Lanka using cancer registry data and comparisons with the incidence in South Asian men in England. BJU Int (2011) 0.80
A one-stop clinic for men with testicular anxiety. Ann R Coll Surg Engl (2009) 0.79
Measurement of insulin-like growth factor axis does not enhance specificity of PSA-based prostate cancer screening. Urology (2004) 0.78
Incidence of bladder cancer in sri lanka: analysis of the cancer registry data and review of the incidence of bladder cancer in the South asian population. Korean J Urol (2012) 0.78
Is the therapeutic action of sildenafil mediated partly through the inhibition of superoxide formation? BJU Int (2005) 0.78
Orthotopic neobladder reconstruction--what are the options? BJU Int (2005) 0.77
Smoking and erectile dysfunction: the role of NADPH oxidase. BJU Int (2004) 0.77
Engineering a biocompatible scaffold with either micrometre or nanometre scale surface topography for promoting protein adsorption and cellular response. Int J Biomater (2013) 0.77
Ultrasonic synthetic technique to manufacture a pHEMA nanopolymeric-based vaccine against the H6N2 avian influenza virus: a preliminary investigation. Int J Nanomedicine (2011) 0.77
Closing the Gender Gap: Can We Improve Bladder Cancer Survival in Women? - A Systematic Review of Diagnosis, Treatment and Outcomes. Urol Int (2016) 0.77
Cavernosal dysfunction in a rabbit model of hyperhomocysteinaemia. BJU Int (2005) 0.77
Re: Oxidative stress in arteriogenic erectile dysfunction: prophylactic role of antioxidants. J Urol (2006) 0.77
Harold Horace Hopkins: a short biography. BJU Int (2010) 0.77
Pre-clinical evidence for the use of phosphodiesterase-5 inhibitors for treating benign prostatic hyperplasia and lower urinary tract symptoms. BJU Int (2006) 0.76
The use of a gas chromatography-sensor system combined with advanced statistical methods, towards the diagnosis of urological malignancies. J Breath Res (2016) 0.75
Re: prostate cancer detection with office based saturation biopsy in a repeat biopsy population. J Urol (2005) 0.75
Photothermal response of CVD synthesized carbon (nano)spheres/aqueous nanofluids for potential application in direct solar absorption collectors: a preliminary investigation. Nanotechnol Sci Appl (2012) 0.75
Re: alfuzosin once daily facilitates return to voiding in patients in acute urinary retention. J Urol (2005) 0.75
Superhydrophobic nature of nanostructures on an indigenous Australian eucalyptus plant and its potential application. Nanotechnol Sci Appl (2011) 0.75
Benign prostatic hyperplasia and sexual dysfunction. Lancet (2003) 0.75
Sexual dysfunction and cardiac risk (the second Princeton Concensus Conference). Am J Cardiol (2005) 0.75
Recovery of erectile function after nerve-sparing radical prostatectomy: improvement with nightly low-dose sildenafil. BJU Int (2009) 0.75
Long-term follow-up of T1 high-grade bladder cancer after intravesical bacille Calmette-Guérin treatment. BJU Int (2011) 0.75
Findings from a prostate cancer screening program in a Japanese population. Asian J Androl (2014) 0.75
Prostate cancer survivorship and psychosexual care. Eur J Cancer Care (Engl) (2015) 0.75
Radiotherapy and surgery for high-risk localized prostate cancer: a UK questionnaire survey of urologists and clinical oncologists. BJU Int (2012) 0.75
The use of chewing gum for preventing postoperative ileus. BJU Int (2007) 0.75
Optimizing the diagnosis of prostate cancer in high-risk men: the supplementary biomarker approach. BJU Int (2005) 0.75
Effect of dilute gelatine on the ultrasonic thermally assisted synthesis of nano hydroxyapatite. Ultrason Sonochem (2010) 0.75
Bladder carcinoma in situ (CIS) in Australia: a rising incidence for an under-reported malignancy. BJU Int (2013) 0.75
Photodynamic diagnostic cystoscopy. BJU Int (2012) 0.75
Prostate cancer survivorship: lifestyle changes, much needed! World J Urol (2014) 0.75
Patient fitness for therapy, a missing element. Eur J Cancer Care (Engl) (2015) 0.75
Do we need to obtain consent for penile shortening as a complication of treatment for organ-confined prostate cancer? BJU Int (2012) 0.75
Fine-tuning of catalytic tin nanoparticles by the reverse micelle method for direct deposition of silicon nanowires by a plasma-enhanced chemical vapour technique. J Colloid Interface Sci (2010) 0.75
The BAUS urological cancer observatory. BJU Int (2009) 0.75
Assessment of a combined gas chromatography mass spectrometer sensor system for detecting biologically relevant volatile compounds. J Breath Res (2017) 0.75
Retroperitoneoscopic nephrectomy for pelvic kidney. Surg Laparosc Endosc Percutan Tech (2007) 0.75
High-intensity focused ultrasound (HIFU) for treating prostate cancer. BJU Int (2005) 0.75